Modelling the impact of population-based cytologic screening on cervical cancer incidence and mortality in Hong Kong: An age-period-cohort approach

British Journal of Cancer

Volumn 93, Issue 9, 2005, Pages 1077-1083

  Woo, P P S ^a   Thach, T Q ^a   Choy, S T B ^b   McGhee, S M ^a   Leung, G M ^a,c,d  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Age period cohort; Bayesian methods; Cervical cancer; Hong Kong; Maximum likelihood estimation; Screening

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; CYTOLOGY; FEMALE; HEALTH SURVEY; HONG KONG; HUMAN; MAJOR CLINICAL STUDY; MATHEMATICAL MODEL; PRIORITY JOURNAL; RISK REDUCTION; UTERINE CERVIX CANCER;

ADULT; AGE DISTRIBUTION; AGED; CERVICAL INTRAEPITHELIAL NEOPLASIA; COHORT STUDIES; FEMALE; HONG KONG; HUMANS; INCIDENCE; MASS SCREENING; MIDDLE AGED; MODELS, THEORETICAL; MORTALITY; UTERINE CERVICAL NEOPLASMS;

EID: 27644564870     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6602805     Document Type: Article

References (30)

1. Anttila A, Nieminen P (2000) Cervical cancer screening programme in Finland. Eur J Cancer 36: 2209-2214
2. Bashir SA, Esteve J (2001) Projecting cancer incidence and mortality using Bayesian age - period - cohort models. J Epidemiol Biostat 6: 287-296
3. Bonneux L (2004) Harms and benefits of screening to prevent cervical cancer. Lancet 364: 1483-1484
4. Bray I (2002) Application of Markov chain Monte Carlo methods to projecting cancer incidence and mortality. J R Stat Soc Appl Stat 51: 151-164
5. Bray I, Brennan P, Boffetta P (2001) Recent trends and future projections of lymphoid neoplasms - a Bayesian age - period - cohort analysis. Cancer Causes Control 12(9): 813-820
6. Breslow NE, Clayton DG (1993) Approximate inference in generalised linear mixed models. J Am Stat Assoc 88: 9-25
7. Department of Health (2003) Annual report 2002/2003. Hong Kong: Government Printers
8. Dillner J (2000) Cervical cancer screening in Sweden. Eur J Cancer 36: 2255-2259
9. Dyba T, Hakulinen T (2000) Comparison of different approaches to incidence prediction based on simple interpolation techniques. Stat Med 19: 1741-1752
10. Eddy DM (1990) Screening for cervical cancer. Arch Intern Med 113(3): 214-226
11. Hakama M, Chamberlain J, Day NE, Miller AB, Prorok PC (1985) Evaluation of screening programmes for gynaecological cancer. Br J Cancer 52: 669-673
12. Herrero R, Brinton LA, Reeves WC, Brenes MM, De Britton RC, Gaitan E, Tenorio F (1992) Screening for cervical cancer in Latin America: a case-control study. Int J Epidemiol 21(6): 1050-1056
13. Hong Kong Census and Statistics Department (2004) Hong Kong Life Tables, 1998-2033. Hong Kong: Government Printers
14. IARC Working Group on Evaluation of Cervical Cancer Screening Programmes (1986) Screening for squamous cervical cancer: duration of low risk after negative results of cervical cytology and its implication for screening policies. BMJ 293: 659-664
15. IARC (2005) IARC Handbooks of Cancer Prevention. Vol. 10: Cervix Cancer Screening. Lyon: IARC Press
16. Laara E, Day N, Hakama M (1987) Trends in mortality from cervical cancer in the Nordic countries: association with organised screening programmes. Lancet 1: 1247-1249
17. La Vecchia C, Franceschi S, Decarli A, Fasoli M, Gentile A, Tognoni G (1984) Pap smear and risk of cervical neoplasia: quantitative estimates from a case-control study. Lancet 2: 779-782
18. Leung GM, Woo PPS, McGhee SM, Cheung ANY, Fan S, Mang O, Thach TQ, Ngan HYS (2005) Age - period - cohort analysis of cervical cancer incidence in Hong Kong using maximum likelihood and Bayesian methods. Int J Cancer 2005 (submitted for publication)
19. McCullagh P, Nelder J (1983) Generalised Linear Models 2nd edn. London: Chapman & Hall
20. Miller AB, Lindsay J, Hill GB (1976) Mortality from cancer of the uterus in Canada and its relationship to screening for cancer of the cervix. Int J Cancer 17(5): 602-612
21. Møller B, Fekjaer H, Hakulinen T, Sigvaldason H, Storm HH, Talback M, Haldorsen T (2003) Prediction of cancer incidence in the Nordic countries: empirical comparison of different approaches. Stat Med 22(17): 2751-2766
22. Murray CJ, Lopez AD (1996) The Global Burden of Disease. Geneva: World Health Organization
23. Negri E, La Vecchia C, Levi F, Randriamiharisoa A, Decarli A, Boyle P (1990) The application of age, period and cohort models to predict Swiss cancer mortality. J Cancer Res Clin Oncol 116(2): 207-214
24. Osmond C (1985) Using age, period and cohort models to estimate future mortality rates. Int J Epidemiol 14: 124-129
25. Peto J, Gilham C, Fletcher O, Matthews FE (2004) The cervical cancer epidemic that screening has prevented in the UK. Lancet 364: 249-256
26. Quinn M, Babb P, Jones J, Allen E, on behalf of the United Kingdom Association of Cancer Registries (1999) Effect of screening on incidence of the mortality from cancer of the cervix in England: evaluation based on routinely collected statistics. BMJ 318: 904-908
27. Quinn M, d'Onofrio A, Møller B, Black R, Martinez-Garcia C, Møller H, Rahu M, Robertson C, Schouten LJ, La Vecchia C, Boyle P (2003) Cancer mortality trends in the EU and acceding countries up to 2015. Ann Oncol 14(7): 1148-1152
28. Rohan TE, Burk RD, Franco EL (2003) Toward a reduction of the global burden of cervical cancer. Am J Obstet Gynecol 189(4 Suppl): S37-S39
29. Taylor RJ, Morrell SL, Mamoon HA, Wain GV (2001) Effects of screening on cervical cancer incidence and mortality in New South Wales implied by influences of period of diagnosis and birth cohort. J Epidemiol Commun Health 55(11): 782-788
30. University of Hong Kong (2005) Population Health Survey Report. Commissioned by Department of Health, Government of the Hong Kong Special Administrative Region, People's Republic of China